Skip navigation
CBI
Compliance Congress for Specialty Products banner ad
Outcomes-Based Contracting Summit banner ad

BioProcessing Conferences

CBI’s Bioprocessing Series – Designed to Deliver

The biopharmaceutical industry is experiencing record growth, fueled by significant technological advances and increased clinical success of diversified product pipelines. The promise and potential of the next generation of therapies has greatly increased expectations for the global biopharmaceutical market, currently valued over $200 billion and estimated to exceed $291 billion by 2021. Despite these growth factors and achievements, companies will continue to face more daunting challenges to achieve clinical and commercial success because the time and cost to bring biologics to market are increasing substantially.

As such, CBI’s Bioprocessing Series has been strategically designed to unite developers and end users to collaborate and examine emerging trends, uncover new opportunities and overcome key challenges to successfully develop and produce the next wave of biotherapeutics. Each event will be serve as a platform to unite leading experts from every department, and stage of development, to collectively tackle a specific challenge in one room — not separated into several tracks with a tradeshow-like setup. This streamlined approach paves the way for a variety of interactive formats that will encourage participation and maximize the conference experience for every attendee. Join us!

To learn more and explore the 2017-2018 conference schedule, please visit www.cbinet.com/bioprocessingseries